Syngeneic Bone Marrow Cell Therapy Prevents Intimal Proliferation in Allogeneic Vascular Transplantation
✍ Scribed by Caroline Freguin-Bouilland; Bassam Alkhatib; Nathalie David; Françoise Lallemand; Jean Paul Bessou; Olivier Boyer; Christian Thuillez; Didier Plissonnier
- Book ID
- 116705654
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 772 KB
- Volume
- 168
- Category
- Article
- ISSN
- 0022-4804
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Mesenchymal stem cells (MSCs) are precursors of tissue of mesenchymal origin, but they also have the capacity to regulate the immune response by suppressing T and B lymphocyte proliferation in a non–major histocompatibility complex–restricted manner. Use of MSCs as immunos
Forty-two cytomegalovlrus (CMV)-seropositive allogeneic marrow transplant patients or recipients of CMV-seropositive marrow allografts were entered Into a surveillance program to detect and treat CMV Infection during the first 120 days posttransplant. CMV Infection was detected at a mean time of day